1-1 of 1
Christopher D. Watt
Close
Sort by
Journal Articles

Gilteritinib induces differentiation in relapsed and refractory FLT3 -mutated acute myeloid leukemia

Clinical Trials & Observations
Christine M. McMahon, Jonathan Canaani, Bryan Rea, Rachel L. Sargent, Julianne N. Qualtieri, Christopher D. Watt, Jennifer J. D. Morrissette, Martin Carroll, Alexander E. Perl
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1581–1585.
https://doi.org/10.1182/bloodadvances.2018029496
Published: 2019
Includes: Supplemental data